A placebo-controlled study on urokinase therapy in systemic sclerosis

Biomedicine and Pharmacotherapy

Volumn 50, Issue 8, 1996, Pages 363-368

  Ciompi, M L ^a   Bazzichi, L ^a   Melchiorre, D ^a   De Giorgio, F ^a   Bondi, F ^a   Puccetti, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Controlled trial; Systemic sclerosis; Urokinase therapy

Indexed keywords

PLACEBO; UROKINASE;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SKIN ULCER; SYSTEMIC SCLEROSIS; ULTRASOUND; VASCULAR LESION;

EID: 0029845558     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(96)89669-7     Document Type: Conference Paper

References (21)

1. Casas JA, Saway PA, Villareal I. 5-Fluorouracil in the treatment of scleroderma: a randomized, double-blind placebo controlled international collaborative study. Ann Rheum Dis 1990;49:926
2. Ciompi ML, Melchiorre D, Bazzichi L, Puccetti L, Evangelisti L. Studio del sistema coagulativo in pazienti con sclerosi sistemica progressiva. Conv Immun E Immunoter Mal Reum, Bologna: June 29-30 1992; p 162
3. Ciompi ML, Melchiorre D, Bazzichi L, Puccetti L, Evangelisti L, Giordani R. Incremento dei D-dimeri nella sclerosi sistemica progressiva (Ssp). Reumatismo 1992;44:128
4. Clements PJ, Lachenbruch PA, Sterz M. Cyclosporine in systemic sclerosis. Results of a forty-eight week open safety study in ten patients. Arthrit Rheum 1981;36:75
5. Dau PC, Kahaleh MB, Sagebiel RW. Plasmapheresis and immunosuppressive drug therapy in scleroderma. Arthrit Rheum 1993;24:1128
6. Dejanna E, Prosdocimi M. Il Laboratorio Endoteliale. Rome: Il Pensiero Scientifico, 1991:103
7. Fenaux P, Merignargues S, Pagnicz D. Cutaneous sclerosis, plastic anemia and antithymocyte globulin. Ann Intern Med 1989;110:575
8. Ferri C, Bernini L, Gremignai G. Plasma exchange in the treatment of progressive systemic sclerosis. Plasma Ther Trans Technol 1987;8:169
9. Furst DE, Clements P, Hillis S. Immunosuppression with chlorambucil versus placebo for scleroderma. Arthrit Rheum 1989;32:584
10. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma systemic sclerosis): classification, subsets and pathogenesis. J Rheum 1988;15:202
11. Medsger TA. Treatment of systemic sclerosis. Ann Rheum Dis 1991;50:877
12. O'Dell JR, Steigerward JC, Kennaugh RC. Lack of clinical benefit after treatment of systemic sclerosis with total lymphoid irradiation. J Rheumatol 1989;16:1050
13. Oriente P. Progressive systemic sclerosis and S-adenosyl-methionine. Clin Rheum 1985;4;360
14. Pepper MS, Scappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993;122:673
15. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthr Rheum 1979;22:130
16. Shimizu Y, Mizutani H, Inachi S, Tsuchibashi T, Shimizu M. Neural blockade, urokinase and prostaglandin E1 combination therapy for acute digital ischemia of progressive systemic sclerosis. J Dermatol 1994;21:755
17. Steen VD. Treatment of systemic sclerosis. Curr Opin Rheum 1991;3:979
18. Steen VD, Medsger Jr TA, Rodnan GP. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma). Ann Intern Med 1982;97:652
19. Steen VD, Powell DL, Medsger Jr TA Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthr Rheum 1988;31:196.
20. Withman III HH, Case DB, LeRoy EC. Management of hypertensive scleroderma patients with converting-enzyme inhibition. In: Myers AR, Black CM, eds. Current Topics in Rheumatology: Systemic (Sclerosis (Scleroderma). New York: Gower Medical, 1985;428
21. Zachariae H, Zachariae E. Cyclosporin A in systemic sclerosis. Br J Dermatol 1987;116:741